Large-scale testing (Phase 3)UnknownNCT01352091What this trial is testingAdjuvant AI Combined With ZoladexWho this might be right forBreast Cancer Fudan University 670
Not applicableActive Not RecruitingNCT05708703What this trial is testingAssessing the Time Demands of CancerWho this might be right forMetastatic Breast CancerOvarian Cancer Masonic Cancer Center, University of Minnesota 78
Large-scale testing (Phase 3)Study completedNCT00390455What this trial is testingFulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-PositiveWho this might be right forEstrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)Study completedNCT00755885What this trial is testingAbiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast CancerWho this might be right forBreast Cancer Cancer Research UK 77
Very early researchStudy completedNCT03832985What this trial is testingPediatric Reporting of Adult-Onset Genomic ResultsWho this might be right forHereditary Breast and Ovarian Cancer SyndromeLynch SyndromeFamilial Hypercholesterolemia Geisinger Clinic 162
Not applicableStudy completedNCT00342446What this trial is testingA Follow-up Study of Women Evaluated and Treated for InfertilityWho this might be right forOvarian CancerBreast CancerEndometrial Cancer+2 more National Cancer Institute (NCI) 12,193
Early research (Phase 1)Looking for participantsNCT07524322What this trial is testingStudy of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid TumorsWho this might be right forBreast CancerOvarian CancerEndometrial Cancer+6 more Regor Pharmaceuticals Inc. 63
Large-scale testing (Phase 3)Study completedNCT00270166What this trial is testingThe Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving ChemotherapyWho this might be right forAnemiaMultiple MyelomaLymphoma+6 more Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 201
Not applicableStudy completedNCT04021602What this trial is testingDiabetes Prevention Program Feasibility Study of BreastfeedingWho this might be right forPregnancyOverweight and Obesity University of Kansas Medical Center 35
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Not applicableEnded earlyNCT02149173What this trial is testingF-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted TherapyWho this might be right forEstrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7 University of Washington 29
Not applicableStudy completedNCT00043472What this trial is testingRemoval of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic RiskWho this might be right forBreast CancerOvarian Cancer National Cancer Institute (NCI) 40
Not applicableUnknownNCT04474951What this trial is testingFood Supplements Based on Nettle and Peppermint to Control Signs and Symptoms Induced by Cancer TherapiesWho this might be right forBreast CancerGynecologic Cancer IRCCS Azienda Ospedaliero-Universitaria di Bologna 60
Not applicableApproved For MarketingNCT04100694What this trial is testingEarly Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid TumorWho this might be right forNRG1 FusionPancreatic CancerNon Small Cell Lung Cancer+8 more Merus B.V.
Testing effectiveness (Phase 2)Active Not RecruitingNCT02764541What this trial is testingPalbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)Who this might be right forBreast Cancer Dana-Farber Cancer Institute 195
Testing effectiveness (Phase 2)UnknownNCT05186545What this trial is testingAn Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast CancerWho this might be right forBreast CancerBreast Cancer Female The First Affiliated Hospital of Zhengzhou University 63
Early research (Phase 1)Study completedNCT00569283What this trial is testingDonor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow TransplantWho this might be right forCancer Asan Medical Center 18
Not applicableStudy completedNCT04817501What this trial is testingPhenotypic Spectrum of CTCs in Tumors of the Female Reproductive SystemWho this might be right forBreast CancerOvarian CancerEndometrial Cancer Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Looking for participantsNCT06400472What this trial is testingLY4170156 in Participants With Selected Advanced Solid TumorsWho this might be right forOvarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more Eli Lilly and Company 495
Not applicableNot Yet RecruitingNCT05848856What this trial is testingThe RISC Registry--Risk Informed Screening RegistryWho this might be right forBreast Cancer RiskCardiovascular Disease RiskCardiometabolic Risk+1 more Precision Health Equity Initiative 10,000